Suvorexant (Belsomra)

suvorexant · Merck & Co.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Suvorexant (Belsomra), covering 2025-07-18 to 2025-07-18. Get the full timeline:

Most recent: Clinical Trial Update: Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress [Phase 4]